Death receptor 3 mediates TNFSF15- and TNFα-induced endothelial cell apoptosis

International Journal of Biochemistry and Cell Biology

Volumn 55, Issue , 2014, Pages 109-118

  Xu, Li Xia ^a   Grimaldo, Sammy ^b   Qi, Jian Wei ^a   Yang, Gui Li ^a   Qin, Ting Ting ^a   Xiao, Huai Yuan ^a   Xiang, Rong ^a,c   Xiao, Zhixiong ^a,d   Li, Lu Yuan ^a   Zhang, Zhi Song ^a  

^a NANKAI UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NANKAI UNIVERSITY   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; Autocrine; Cytokine; Death receptor

Indexed keywords

DEATH RECEPTOR 3; FLICE INHIBITORY PROTEIN; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL 2; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; CASPASE; CFLAR PROTEIN, MOUSE; DOXORUBICIN; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT PROTEIN; TNFSF15 PROTEIN, RAT; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR SUPERFAMILY 15; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ANGIOGENESIS ASSAY; ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY ASSAY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; GENE SILENCING; NONHUMAN; UPREGULATION; ANIMAL; BOVINE; C57BL MOUSE; CELL LINE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; CATTLE; CELL GROWTH; CYTOTOXICITY; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INFANT; MOUSE; PROTEIN DEPLETION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CATTLE; CELL LINE; DOXORUBICIN; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907320822     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.08.015     Document Type: Article

References (50)

1. S.J. Baker, and E.P. Reddy Modulation of life and death by the TNF receptor superfamily Oncogene 17 1998 3261 3270
2. T. Bertani, M. Abbate, C. Zoja, D. Corna, N. Perico, and P. Ghezzi et al. Tumor necrosis factor induces glomerular damage in the rabbit Am J Pathol 134 1989 419
3. G.M. Birdsey, N.H. Dryden, V. Amsellem, F. Gebhardt, K. Sahnan, and D.O. Haskard et al. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin Blood 111 2008 3498 3506
4. C. Bossen, K. Ingold, A. Tardivel, J.L. Bodmer, O. Gaide, and S. Hertig et al. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human J Biol Chem 281 2006 13964 13971
5. S-S. Chae, J-H. Paik, H. Furneaux, and T. Hla Requirement for sphingosine 1 - phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference J Clin Investig 114 2004 1082 1089
6. L.J. Chew, H.G. Pan, J.Y. Yu, S. Tian, W.Q. Huang, and J.Y. et al. Zhang A novel secreted splice variant of vascular endothelial cell growth inhibitor Faseb J 16 2002 742
7. A.C. Childs, S.L. Phaneuf, A.J. Dirks, T. Phillips, and C. Leeuwenburgh Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio Cancer Res 62 2002 4592 4598
8. A.M. Chinnaiyan, K. O'Rourke, G.L. Yu, R.H. Lyons, M. Garg, and D.R. Duan et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 Science 274 1996 990 992
9. J.C. Choy, D.J. Granville, D.W. Hunt, and B.M. McManus Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis J Mol Cell Cardiol 33 2001 1673 1690
10. W. Deng, X. Gu, Y. Lu, C. Gu, Y. Zheng, and Z. Zhang et al. Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization Angiogenesis 15 2012 71 85
11. O. Dumont, H. Mylroie, A. Bauer, D. Calay, A. Sperone, and C. Thornton et al. Protein kinase cepsilon activity induces anti-inflammatory and anti-apoptotic genes via an ERK1/2- and NF-kappa B-dependent pathway to enhance vascular protection Biochem J 447 2012 193 204
12. J.M.L. Ebos, and R.S. Kerbel Antiangiogenic therapy: impact on invasion, disease progression, and metastasis Nat Rev Clin Oncol 8 2011 210 221
13. K. Faucher, H. Rabinovitch-Chable, J. Cook-Moreau, G. Barriere, F. Sturtz, and M. Rigaud Overexpression of human GPX1 modifies Bax to Bcl-2 apoptotic ratio in human endothelial cells Mol Cell Biochem 277 2005 81 87
14. W.J. Feng, X.Z. Xu, G. Zhao, G. Li, T.T. Liu, and J.J. Zhao et al. EETs and CYP2J2 inhibit TNF-alpha-induced apoptosis in pulmonary artery endothelial cells and TGF-beta 1-induced migration in pulmonary artery smooth muscle cells Int J Mol Med 32 2013 685 693
15. J. Folkman Angiogenesis-dependent diseases Sem Oncol 28 2001 536 542
16. S. Grimaldo, F. Tian, and L.Y. Li Sensitization of endothelial cells to VEGI-induced apoptosis by inhibiting the NF-kappaB pathway Apoptosis 14 2009 788 795
17. S.W. Hetts To die or not to die: an overview of apoptosis and its role in disease JAMA 279 1998 300 307
18. S. Hippenstiel, B. Schmeck, J. Seybold, M. Krull, O. Fuhrman, and K.T. Preissner et al. Rho protein inactivation induces endothelial cell apoptosis - sensitization towards TNF-alpha-dependent programmed cell death via NF-kappa B-inhibition Am J Resp Crit Care 159 1999 A186-A
19. D.C. Hocking, P.G. Phillips, T.J. Ferro, and A. Johnson Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha Circ Res 67 1990 68 77
20. W. Hou, D. Medynski, S. Wu, X. Lin, and L.Y.V.E.G.I-192 Li a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth Clin Cancer Res: Off J Am Assoc Cancer Res 11 2005 5595 5602
21. T. Kataoka The caspase-8 modulator c-FLIP Crit Rev Immunol 25 2005 31 58
22. M.M. Kelly, B.D. Hoel, and C. Voelkel-Johnson Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression Cancer Biol Ther 1 2002 520 527
23. P.H. Liang, F. Tian, Y. Lu, B. Duan, D.B. Stolz, and L.-Y. Li Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors Angiogenesis 14 2011 61 68
24. E. Lorenzo, C. Ruiz-Ruiz, A.J. Quesada, G. Hernandez, A. Rodriguez, and A. Lopez-Rivas et al. Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism J Biol Chem 277 2002 10883 10892
25. L.A. Madge, and J.S. Pober TNF can elicit apoptosis of human umbilical vein endothelial cells by either type I or type II cell death pathways Arterioscl Throm Vas 21 2001 699
26. Z. Mallat, and A. Tedgui Apoptosis in the vasculature: mechanisms and functional importance Br J Pharmacol 130 2000 947 962
27. T. Matsumoto, I. Turesson, M. Book, P. Gerwins, and L. Claesson-Welsh p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis J Cell Biol 156 2002 149 160
28. F. Meylan, T.S. Davidson, E. Kahle, M. Kinder, K. Acharya, and D. Jankovic et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases Immunity 29 2008 79 89
29. T.S. Migone, J. Zhang, X. Luo, L. Zhuang, C. Chen, and B. Hu et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator Immunity 16 2002 479 492
30. W. Min, T. Wan, and Y. Luo Dissecting TNF-TNFR1/TNFR2 signaling pathways in vasculature S. Dauphinee, A. Karsan, Endothelial Dysfunction and Inflammation 2010 Springer Basel AG Basel Switzerland 137 159
31. K.A. Papadakis, D. Zhu, J.L. Prehn, C. Landers, A. Avanesyan, and G. Lafkas et al. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes J Immunol 174 2005 4985 4990
32. A. Pecci, A. Scholz, D. Pelster, and M. Beato Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-X L tobcl-X S J Biol Chem 272 1997 11791 11798
33. K. Pfeffer Biological functions of tumor necrosis factor cytokines and their receptors Cytokine Growth Factor Rev 14 2003 185 191
34. Y.L. Pobezinskaya, S. Choksi, M.J. Morgan, X. Cao, and Z.G. Liu The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling J Immunol 186 2011 5212 5216
35. V.A. Polunovsky, C.H. Wendt, D.H. Ingbar, M.S. Peterson, and P.B. Bitterman Induction of endothelial cell apoptosis by TNFα: modulation by inhibitors of protein synthesis Exp Cell Res 214 1994 584 594
36. J.W. Qi, T.T. Qin, L.X. Xu, K. Zhang, G.L. Yang, and J. Li et al. TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1 Proc Natl Acad Sci U S A 110 2013 13863 13868
37. I. Spyridopoulos, E. Brogi, M. Kearney, A.B. Sullivan, C. Cetrulo, and J.M. Isner et al. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals (vol. 29, pg 1321, 1997) J Mol Cell Cardiol 30 1998 897
38. F. Tian, S. Grimaldo, M. Fujita, J. Cutts, N.L. Vujanovic, and L.Y. Li The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation J Immunol 179 2007 3742 3751
39. F. Tian, P.H. Liang, and L-Y. Li Inhibition of endothelial progenitor cell differentiation by VEGI Blood 113 2009 5352 5360
40. K.J. Tracey, and A. Cerami Tumor necrosis factor, other cytokines and disease Annu Rev Cell Biol 9 1993 317 343
41. J.P. Twohig, M. Marsden, S.M. Cuff, J.R. Ferdinand, A.M. Gallimore, and W.V. Perks et al. The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4+ and CD8+ T-cell immunity FASEB J 26 2012 3575 3586
42. R. van Horssen, T.L.M. ten Hagen, and A.M.M. Eggermont TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility Oncologist 11 2006 397 408
43. H. Walczak TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer Immunol Rev 244 2011 9 28
44. W. Wang, C.Z. Prince, Y. Mou, and M.J. Pollman Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation, resistance to Fas ligand-induced apoptosis J Biol Chem 277 2002 21723 21729
45. L. Wen, L. Zhuang, X. Luo, and P. Wei TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells J Biol Chem 278 2003 39251 39258
46. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
47. C.-R. Yang, S.-L. Hsieh, C.-M. Teng, F.-M. Ho, W.-L. Su, and W.-W. Lin Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action Cancer Res 64 2004 1122 1129
48. J. Yu, S. Tian, L. Metheny-Barlow, L.J. Chew, A.J. Hayes, and H. Pan et al. Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor Circ Res 89 2001 1161 1167
49. Y. Zhai, J. Ni, G.W. Jiang, J. Lu, L. Xing, and C. Lincoln et al. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo Faseb J 13 1999 181 189
50. Y. Zhai, J. Yu, L. Iruela-Arispe, W.Q. Huang, Z. Wang, and A.J. Hayes et al. Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily Int J Cancer 82 1999 131 136